发明名称 |
COMBINATION OF HMG-COA REDUCTASE INHIBITOR ROSUVASTATIN WITH A PHOSPHODIESTERASE 4 INHIBITOR, SUCH AS ROFLUMILAST, ROFLUMILAST-N-OXIDE FOR THE TREATMENT OF INFLAMMATORY PULMONARY DISEASES |
摘要 |
The invention relates to the combined use of a PDE4 inhibitor with a HMG-CoA reductase inhibitor for the preventive and curative treatment of an inflammatory pulmonary disease, wherein the PDE4 inhibitor is selected from the group consisting of ROFLUMILAST, a pharmaceutically acceptable salt of ROFLUMILAST, ROFLUMILAST-N-oxide and a pharmaceutically acceptable salt of ROFLUMILAST-N-oxide, the HMG-CoA reductase inhibitor is ROSUVASTATIN or a pharmaceutically acceptable salt thereof. |
申请公布号 |
HRP20140073(T1) |
申请公布日期 |
2014.02.28 |
申请号 |
HR2014P000073T |
申请日期 |
2014.01.21 |
申请人 |
TAKEDA GMBH |
发明人 |
WOLLIN, STEFAN-LUTZ;WOHLSEN, ANDREA;BRAUN, CLEMENS;MARX, DEGENHARD |
分类号 |
A61K31/44;A61K31/22;A61K31/277;A61K31/343;A61K31/352;A61K31/366;A61K31/40;A61K31/405;A61K31/437;A61K31/4439;A61K31/453;A61K31/502;A61K31/505;A61K45/06;A61P11/00 |
主分类号 |
A61K31/44 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|